Renal haemodynamics changes in different course of type 2 diabetes mellitus on the Contrast Enhanced Ultrasound evidences
https://doi.org/10.24884/1682-6655-2023-22-1-24-33
Abstract
Introduction. The currently used ionizing or invasive instrumental methods are considered to be unsuitable for haemodymanics monitoring. Contrast Enhanced ultrasound (CEUS) can provide better images of renal blood flow. Objective. To assess the renal haemodynamics changes in patients with different course of type 2 diabetes on the CEUS evidences. Materials and methods. From 2019 to 2022 118 patients 62 women (52.5 %), 56 men (47.5 %), average age 64±5.2) were examined. The control group was (n=48). The same study design used for all patients included case history, physical examination, SR-36 and DEBQ questionnaires, laboratory examination, multiparametric examination, CEUS. Results. When assessing BMI the 41.02 %, 52.27 % and 42.85 % of patients were found to be overweighted in the 1, 2 and 3 groups, respectively. By the ROC analysis the quantitative parameters of the CUI were obtained: on day 1 AUC=0.6544, after 6 months AUC=0.6492, after 12 months AUC=0.7418, after 24 months AUC=0.7515, after 36 months AUC=0.7529. For ΔPI according to the data, the optimal threshold for cutting off the transition of diabetic kidney disease to CKD is 76.3 dB. Conclusions. 1. The use of ultrasound contrast agents in the diagnosis of CKD enhances the importance of the ultrasound method. 2. qualitative and quantitative parameters of the CUSI allow to assess the renal haemodynamics changes in patients with different course of type 2 diabetes. 3. ΔPI corresponds to a high quality of prognostic model for the CKD dynamics (AUC=0.7418) with an optimal threshold for cutting off the transition of diabetic disease kidneys in CKD 76.3 dB.
About the Authors
A. V. Borsukov
Smolensk State Medical University
Russian Federation
Russian Federation
Borsukov Alexey V. – Professor, MD, the Head of Fundamental research laboratory «Diagnostic researches and minimally invasive technologies»
28, Krupskoy str., Smolensk, 214019
O. A. Gorbatenko
Smolensk State Medical University
Russian Federation
Russian Federation
Gorbatenko Olga A. – post-graduate student of Fundamental research laboratory «Diagnostic researches and minimally invasive technologies»
28, Krupskoy str., Smolensk, 214019
References
1. Han B.H., Park S.B. Usefulness of Contrast-enhanced Ultrasound in the Evaluation of Chronic Kidney Disease. Curr. Med. Imaging. 2021;17(8):1003–1009. DOI: 10.2174/15734 05617666210127101926.
2. International Diabetes Federation, 2019. URL: https://www.idf.org/
3. Jeong S., Park S.B., Kim S.H., Hwang J.H., Shin J. Clinical significance of contrast-enhanced ultrasound in chronic kidney disease: a pilot study. J. Ultrasound. 2019;22(4): 53–460. DOI: 10.1007/s40477-019-00409-x.
4. Kazmierski B., Deurdulian C., Tchelepi H., Grant E.G. Applications of contrast-enhanced ultrasound in the kidney. Abdom Radiol (NY). 2018;43(4):880–898. DOI: 10.1007/s00261-017-1307-0.
5. Gromov A.I. Diagnostic efficiency of new methods of ultrasound examination in urology. Radiology – praktika. 2012;2:45–52. (In Russ.).
6. Selby N.M., Williams J.P., Phillips B.E. Application of dynamic contrast enhanced ultrasound in the assessment of kidney diseases. Curr. Opin. Nephrol. Hypertens. 2021;30(1):138– 143. DOI: 10.1097/MNH.0000000000000664.
7. Malhi H., Grant E.G., Duddalwar V. Contrast-enhanced ultrasound of the liver and kidney. Radiol. Clin. North Amer. 2014;52(6):1177–1190. DOI: 10.1016/j.rcl.2014.07.005.
8. Zubarev A.V., Fedorova A.A., Chernyshev V.V. et al. The use of echocontrast drugs in the clinic and prospects for synchronization of ultrasound, CT/ MRI images (own experience and literature review). Med. Imaging. 2015;1:94–114. (In Russ.)
9. Daghini E., Primak A.N., Chade A.R., Krier J.D., Zhu X.Y., Ritman E.L., McCollough C.H., Lerman L.O. Assessment of renal hemodynamics and function in pigs with 64-section multidetector CT: comparison with electron-beam CT. Radiology. 2007;243(2):405–412.
10. Herget-Rosenthal S. Imaging techniques in the management of chronic kidney disease: current developments and future perspectives. Seminars. Nephrol. 2011;31(3):283–290.
11. Bertolotto M., Quaia E., Galli G. et al. Color Doppler sonographic appearance of renal perforating vessels in subjects with normal and impaired renal function. J. Clin. Ultrasound. 2000;28(6):267–276.
12. Weskott H.-P. Контрастная сонография (1-е изд). Бремен: UNI-MED; 2014: 284.
13. Borsukov A.V., Gorbatenko O.A. Standardization of the technique of contrastenhanced ultrasound examination of kidneys in patients with type 2 diabetes mellitus. Med. Imaging. 2021;25(3):50–65. (In Russ.) DOI: 10.24835/1607-0763-978.
14. European Society of Uroradiologists. http://www.esur.org
15. Arutyunyan V.M., Mikaelyan E.S., Bagdasaryan A.S. Diabeticheskij glomeruloskleroz. Erevan: Gitutyun NAN RA; 2000: 184 p. (In Russ.)
16. Касаткина Э.П. Сахарный диабет у детей и подростков. М.: Медицина; 1996: 157–201.
17. Dalla Vestra M., Saller A., Bortolozo E. et al. Structural involvement in type 1 and type 2 diabetic nephropathy. Diabet. Metab. 2000;26(4):8–14.
18. Mogensen C.E. Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int. 1987;31:673–689. DOI: 10.1038/ki.1987.50
19. Galesic K., Brkljacic В., Sabljar-Matovinovic M. et al. Renal vascular resistance in essential hypertension: duplex-Doppler ultrasonographic evaluation. Angiology. 2000;51(8):667–675.
20. Wiesinger I., Wiggermann P., Zausig N. et al. Percutaneous treatment of malignant liver lesions: evaluation of success using contrast enhanced ultrasound (CEUS) and perfusion software. Ultraschall Med. 2018;39:440–447. DOI: 10.1055/s-0043-119353.
21. Bagri A. В., Khomenko M.V., Shverova O.I., Titievskaya E.R. Therapy approaches in diabetic nephropathy (review of literature). Nephrology. 2021;25(1):18–30. (In Russ.) DOI: 10.36485/1561-6274-2021-25-1-18-30.
22. Sidhu P.S., Cantisani V., Dietrich C.F. et al. The EFSUMB Guidelines and Recommendation for Clinical Practice of Contrast –Enchanced Ultrasound (CEUS) in Non-Hepatic Applications: Update 2017 Ultraschall Med. 2018;39:2–44.
23. Cantisani V.,Ricci P., Erturk M. et al. Detection of hepatic metastases from colorectal cancer: prospective evaluation of gray scale US versus SonoVue(R) low mechanical index real time-enhanced US as compared with multidetector-CT or Gd-BOPTA-MRI Ultraschall Med. 2010;31:500–505.
24. Klinger C., Stuckmann G., Dietrich C.F. et al. Contrastenhanced imaging in hepatic epithelioid hemangioendothelioma: retrospective study of 10 patients J. Gastroenterol. 2019;57:753–766.
Review
For citations:
Borsukov A.V., Gorbatenko O.A. Renal haemodynamics changes in different course of type 2 diabetes mellitus on the Contrast Enhanced Ultrasound evidences. Regional blood circulation and microcirculation. 2023;22(1):24-33. (In Russ.) https://doi.org/10.24884/1682-6655-2023-22-1-24-33
Views:
438
Email this article 
